Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis

BackgroundMultiple myeloma (MM) is an incurable malignant plasma cell tumor. Whole blood cell count (WBCC) derived indexes are widely used as a predictive biomarker for various types of solid and hematological malignant tumors. Our study is to evaluate its effectiveness in MM by meta-analysis.Method...

Full description

Bibliographic Details
Main Authors: Xinwen Zhang, Jialin Duan, Zhenyu Wen, Hao Xiong, Xiaomin Chen, Yang Liu, Kunyu Liao, Chunlan Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.766672/full
_version_ 1819012977262592000
author Xinwen Zhang
Xinwen Zhang
Jialin Duan
Jialin Duan
Zhenyu Wen
Hao Xiong
Hao Xiong
Xiaomin Chen
Xiaomin Chen
Yang Liu
Yang Liu
Kunyu Liao
Kunyu Liao
Chunlan Huang
Chunlan Huang
author_facet Xinwen Zhang
Xinwen Zhang
Jialin Duan
Jialin Duan
Zhenyu Wen
Hao Xiong
Hao Xiong
Xiaomin Chen
Xiaomin Chen
Yang Liu
Yang Liu
Kunyu Liao
Kunyu Liao
Chunlan Huang
Chunlan Huang
author_sort Xinwen Zhang
collection DOAJ
description BackgroundMultiple myeloma (MM) is an incurable malignant plasma cell tumor. Whole blood cell count (WBCC) derived indexes are widely used as a predictive biomarker for various types of solid and hematological malignant tumors. Our study is to evaluate its effectiveness in MM by meta-analysis.MethodsRelevant literatures were retrieved from PubMed, Embase and Web of Science databases according to PRISMA guideline. All relevant parameters were extracted and combined for statistical analysis.ResultsNineteen studies incorporating 3818 MM patients were eventually included in this meta-analysis. 13 studies evaluated that elevated NLR was significantly associated with poor survival outcomes (OS: HR=2.04, P<0.001; PFS: HR=1.96, P=0.003). Elevated NLR was revealed to correlate with ISS stage (ISS III VS I-II, OR=2.23, P=0.003). A total of 7 studies have shown that elevated LMR predicts a better prognosis in MM patients (OS: HR=0.57, P<0.001; PFS: HR=0.49, P<0.05), and two other studies demonstrated that increased MLR was related to poor OS/PFS (OS: HR=1.58, P<0.05; PFS: HR=1.60, P<0.05). However, in the other 6 studies including 1560 patients, the prognostic value of PLR had not been confirmed (OS: HR=0.89, P>0.05; PFS: HR=0.87, P>0.05).ConclusionsThe indexes NLR and LMR/MLR derived from WBCC were validated to be useful biomarkers to predict the prognosis in MM patients, but the evidence of PLR was insufficient.
first_indexed 2024-12-21T01:52:37Z
format Article
id doaj.art-eec690c52bbb4f60b59c45289f1ae5ee
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-21T01:52:37Z
publishDate 2021-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-eec690c52bbb4f60b59c45289f1ae5ee2022-12-21T19:19:51ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-11-011110.3389/fonc.2021.766672766672Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-AnalysisXinwen Zhang0Xinwen Zhang1Jialin Duan2Jialin Duan3Zhenyu Wen4Hao Xiong5Hao Xiong6Xiaomin Chen7Xiaomin Chen8Yang Liu9Yang Liu10Kunyu Liao11Kunyu Liao12Chunlan Huang13Chunlan Huang14Stem Cell Laboratory, Affiliated Hospital of Southwest Medical University, Luzhou, ChinaDepartment of Hematology, Affiliated Hospital of Southwest Medical University, Luzhou, ChinaStem Cell Laboratory, Affiliated Hospital of Southwest Medical University, Luzhou, ChinaDepartment of Hematology, Affiliated Hospital of Southwest Medical University, Luzhou, ChinaDepartment of Orthopedics, Affiliated Hospital of Southwest Medical University, Luzhou, ChinaStem Cell Laboratory, Affiliated Hospital of Southwest Medical University, Luzhou, ChinaDepartment of Hematology, Affiliated Hospital of Southwest Medical University, Luzhou, ChinaStem Cell Laboratory, Affiliated Hospital of Southwest Medical University, Luzhou, ChinaDepartment of Hematology, Affiliated Hospital of Southwest Medical University, Luzhou, ChinaStem Cell Laboratory, Affiliated Hospital of Southwest Medical University, Luzhou, ChinaDepartment of Hematology, Affiliated Hospital of Southwest Medical University, Luzhou, ChinaStem Cell Laboratory, Affiliated Hospital of Southwest Medical University, Luzhou, ChinaDepartment of Hematology, Affiliated Hospital of Southwest Medical University, Luzhou, ChinaStem Cell Laboratory, Affiliated Hospital of Southwest Medical University, Luzhou, ChinaDepartment of Hematology, Affiliated Hospital of Southwest Medical University, Luzhou, ChinaBackgroundMultiple myeloma (MM) is an incurable malignant plasma cell tumor. Whole blood cell count (WBCC) derived indexes are widely used as a predictive biomarker for various types of solid and hematological malignant tumors. Our study is to evaluate its effectiveness in MM by meta-analysis.MethodsRelevant literatures were retrieved from PubMed, Embase and Web of Science databases according to PRISMA guideline. All relevant parameters were extracted and combined for statistical analysis.ResultsNineteen studies incorporating 3818 MM patients were eventually included in this meta-analysis. 13 studies evaluated that elevated NLR was significantly associated with poor survival outcomes (OS: HR=2.04, P<0.001; PFS: HR=1.96, P=0.003). Elevated NLR was revealed to correlate with ISS stage (ISS III VS I-II, OR=2.23, P=0.003). A total of 7 studies have shown that elevated LMR predicts a better prognosis in MM patients (OS: HR=0.57, P<0.001; PFS: HR=0.49, P<0.05), and two other studies demonstrated that increased MLR was related to poor OS/PFS (OS: HR=1.58, P<0.05; PFS: HR=1.60, P<0.05). However, in the other 6 studies including 1560 patients, the prognostic value of PLR had not been confirmed (OS: HR=0.89, P>0.05; PFS: HR=0.87, P>0.05).ConclusionsThe indexes NLR and LMR/MLR derived from WBCC were validated to be useful biomarkers to predict the prognosis in MM patients, but the evidence of PLR was insufficient.https://www.frontiersin.org/articles/10.3389/fonc.2021.766672/fullmultiple myeloma (MM)neutrophil-to-lymphocyte ratio (NLR)platelet-to-lymphocyte ratio (PLR)lymphocyte-to-monocyte ratio (LMR)monocyte-to-lymphocyte ratio (MLR)prognosis
spellingShingle Xinwen Zhang
Xinwen Zhang
Jialin Duan
Jialin Duan
Zhenyu Wen
Hao Xiong
Hao Xiong
Xiaomin Chen
Xiaomin Chen
Yang Liu
Yang Liu
Kunyu Liao
Kunyu Liao
Chunlan Huang
Chunlan Huang
Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis
Frontiers in Oncology
multiple myeloma (MM)
neutrophil-to-lymphocyte ratio (NLR)
platelet-to-lymphocyte ratio (PLR)
lymphocyte-to-monocyte ratio (LMR)
monocyte-to-lymphocyte ratio (MLR)
prognosis
title Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis
title_full Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis
title_fullStr Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis
title_full_unstemmed Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis
title_short Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis
title_sort are the derived indexes of peripheral whole blood cell counts nlr plr lmr mlr clinically significant prognostic biomarkers in multiple myeloma a systematic review and meta analysis
topic multiple myeloma (MM)
neutrophil-to-lymphocyte ratio (NLR)
platelet-to-lymphocyte ratio (PLR)
lymphocyte-to-monocyte ratio (LMR)
monocyte-to-lymphocyte ratio (MLR)
prognosis
url https://www.frontiersin.org/articles/10.3389/fonc.2021.766672/full
work_keys_str_mv AT xinwenzhang arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT xinwenzhang arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT jialinduan arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT jialinduan arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT zhenyuwen arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT haoxiong arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT haoxiong arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT xiaominchen arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT xiaominchen arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT yangliu arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT yangliu arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT kunyuliao arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT kunyuliao arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT chunlanhuang arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis
AT chunlanhuang arethederivedindexesofperipheralwholebloodcellcountsnlrplrlmrmlrclinicallysignificantprognosticbiomarkersinmultiplemyelomaasystematicreviewandmetaanalysis